Italy· 047317021
VILDAGLIPTIN AUROBINDO
A vildagliptin product containing vildagliptin, registered in Italy by AUROBINDO PHARMA ITALIA S.R.L., on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against AIFA (Italy) on
Informational only — not a medical device.
Where it is registered
Vildagliptin is registered in 16 of 19 countries.
Countries holding a registration under ATC A10BH02 (vildagliptin), each read from that country’s own register.
- This record: Italy, from AIFA (Italy)
- 9 of them publish a price we can compare per daily dose
Vildagliptin · ATC A10BH02
16 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of vildagliptin costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.32 in France to $1.98 in Switzerland — a ×6.2 gap.
- Italy: $1.0 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Vildagliptin · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.98
- IT Italy$1.0
- FR France$0.32
The record
At a glance
AIFA (Italy)- Active substance
- Vildagliptin
- Manufacturer
- AUROBINDO PHARMA ITALIA S.R.L.
- Country
- Italy (IT)
- ATC code
- A10BH02
- ATC class
- Vildagliptin
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Yes
- Source register
- AIFA (Italy)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- aic047317021"50 MG COMPRESSE" 56 COMPRESSE IN BLISTER OPA/AL/PVC-ALEUR 24.5
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A10BH02
Vildagliptin, as other registers publish it.
- PolandAgnisBelupo lijekovi i kozmetika d.d.
- PolandAlikvalEgis Pharmaceuticals PLC
- CzechiaALIKVALEgis Pharmaceuticals PLC, Budapešť
- CzechiaALIKVALEgis Pharmaceuticals PLC, Budapešť
- CzechiaALIKVALEgis Pharmaceuticals PLC, Budapešť
- CzechiaALIKVALEgis Pharmaceuticals PLC, Budapešť
- CzechiaALIKVALEgis Pharmaceuticals PLC, Budapešť
- CzechiaALIKVALEgis Pharmaceuticals PLC, Budapešť
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d9eff749-8174-4f23-9f92-113e818b9d49 GET /v1/drugs/d9eff749-8174-4f23-9f92-113e818b9d49?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pack": "\"50 MG COMPRESSE\" 56 COMPRESSE IN BLISTER OPA/AL/PVC-AL",
"source": "aifa",
"currency": "EUR",
"substance": "Vildagliptin",
"reference_pack": "56 UNITA' 50 MG - USO ORALE",
"public_price_eur": 24.5,
"ssn_reference_price_eur": 24.5
}See everything about vildagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.